Clinical Trials market in India has shown significant growth symptoms in the recent past. Clinical research experienced over 84% growth during 2006-2008 and it has its own merit in regards to further prospect considering global clinical market is growing at 12%. Clinical research industry in India touched US8 million in 2008, up from US0 million in 2006. An estimate shows that clinical research in India is expected to be US0 million by 2009. The cost of conducting clinical trials in India, for instance, is 20 to 60 per cent of the cost in developed countries. Not surprisingly, about 20 to 30 per cent of the clinical development activity is now outsourced to developing countries such as India. Currently, there are more than 150 CROs in India, out of which 20 comply with ICH-GCP guidelines. The leading players in India include Clinigene International, Vimta Labs Ltd, and Lotus labs, besides multinationals like Quintiles Spectral, Pharmanet, SIRO Clinpharm and Clintec, etc.
In view of the growth potential and Indias strength in pharmaceuticals to qualify for clinical trials Cygnus has come out with an updated version of the Clinical trials report. The report has total 9 chapters and all chapters are covered in such a fashion that one can understand all aspects of clinical trails industry in India well. This report mostly captures secondary information collected from various reliable information sources covering market information, company specific vital information, issues and challenges, growth drivers and future outlook.
The report will be useful for research analysts in the clinical research space, investors interested in clinical research based companies, students for clinical research who want to pursue career in CROs and various pharma companies who want to understand Indian clinical research industry in India.
No of Pages: 308 No of Figures: 09 No of Tables: 07

Table of Contents :
EXECUTIVE SUMMARY,HIGHLIGHTS,1. INTRODUCTION,1.1 A Brief History,1.2 Effectiveness and Safety,1.3 Clinical Trials: Benefits galore,1.3.1 Research and Innovation,1.3.2 Indian companies increase their R&D spending,1.3.3 Investigational New Drug application (IND), 1.4 Global Scenario,1.5 Indian Scenario,1.5.1 Rising tide of research and clinical trials,1.5.2 India as a destination for CROs,1.5.3 Potential of CRO industry,1.5.4 Field Trials (Clinical Trials),1.5.5 Major Diseases,1.5.6 Infrastructure facilities,1.5.7 Competitors in the sector,1.5.8 Laboratory Trials (Pre-clinical trials),1.5.9 Recent Trends ,1.5.10 Trends in Drug Development, 1.5.11 Regulatory Developments, 1.5.12 Ethical Review Boards,2. MARKET SCENARIO,2.1 Global Scenario, , 2.1.1 Laboratory-developed Tests, 2.1.2 Inspections, 2.1.3 Education and Training Requirements, 2.1.4 Quality Control, 2.2 R&D Expenditure, 2.3 Drug withdrawals/Clinical Trial failures, 2.4 Research on Drug Price Controls, 2.4.1 Loss of Future Drug Therapy, 2.4.2 Slowdown in Drug Availability, 2.5 Indian Scenario, 2.5.1 Indian Companies, 2.5.2 Multinational Companies, 2.5.3 Business model (Models of clinical trials outsourcing), 2.5.4 Target customers, 2.5.5 R&D Budget Break up, 2.5.6. Advantages offered by India in Clinical trials domain, 2.5.7 Outsourcing Clinical trials, 2.5.8 Clinical Trial components, 2.5.9 Market related factors, 3. MAJOR PLAYERS, 3.1 The Players, Listed in BSE/NSE, 3.1.1 Clinigene, 3.1.2 Dr. Reddy’s Laboratories Limited, 3.1.3 GlaxoSmithKline, 3.1.4 Lupin Limited, 3.1.5 Novartis, 3.1.6 Pfizer Limited, 3.1.7 Daiichi Sankyo, 3.1.8 Torrent Pharmaceuticals Limited, 3.1.9 Vimta Labs Limited, 3.1.10 Cadila healthcare, Unlisted in BSE/NSE, 3.1.11 Asian Clinical Trials Limited, 3.1.12 Bioserve Clinical Research Pvt. Ltd., 3.1.

For more information please contact :

http://www.aarkstore.com/reports/Clinical-trials-Market-in-India-12543.html

http://www.emarketreports.com

http://www.aarkwebsolutions.com/

From:Aarkstore Enterprise
Contact: Neel
Email: press@aarkstore.com
URL: www.aarkstore.com